Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prescrire is an independent, non-profit organization and medical journal based in France that provides healthcare professionals with evidence-based evaluations of medicines and therapeutic strategies. Established in 1981, the organization is renowned for its total financial independence, as it refuses all advertising, grants, and industry funding, relying solely on subscriber revenue. Its primary publication, the monthly journal "Prescrire," offers rigorous assessments of new drugs, comparative effectiveness reviews, and pharmacovigilance updates. Prescrire also publishes an English-language edition, "Prescrire International," to reach a global audience of clinicians and researchers. The organization plays a critical role in the healthcare ecosystem by identifying "drugs to avoid" and promoting rational prescribing practices. It is a founding member of the International Society of Drug Bulletins (ISDB).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revue Prescrire.